why choose us

First received: November 21, 2022

Clinical Trial: Study of Novel Treatment Combinations in Patients With Lung Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Lung Cancer

Study Type: INTERVENTIONAL


Official Title: A Phase 2 Platform Study Evaluating the Safety and Efficacy of Novel Treatment Combinations in Patients With Lung Cancer (VELOCITY-Lung)

Brief Summary: The goal of this platform clinical trial is to test how well novel treatment combinations work in participants with lung cancer.Substudy-01 will compare the different novel combinations versus standard of care in participants with metastatic (cancer that has spread) non-small-cell lung cancer (NSCLC) who have have not been treated before.Substudy-02 will compare the different novel combination versus standard of care in participants with cancer that has progressed after receiving previous treatment for metastatic…

Read more